2026 NPPES data Podiatrist NPI 1639132640 D.P.M.
Verify on CMS →

ROBERT KLEIMAN, D.P.M.

Podiatrist in CALEXICO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 418 beneficiaries · Podiatrist avg: 304
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ROBERT KLEIMAN, D.P.M. filed 2,454 Medicare Part D claims in 2023 as a Podiatrist in CALEXICO, California, prescribing 94% generic.

2K
Part D claims, 2023
94%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT KLEIMAN, D.P.M.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,454 Top 14% higher than 86% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ROBERT KLEIMAN, D.P.M.?

Quality data not reported

NPI registry status

Active

Issued 04/10/2006

NPI 1639132640

Primary specialty

Podiatrist

Mid-sized

10,498 US NPIs in this specialty

Medicare Part D claims

2,454 707% vs specialty avg

2023 prescription claims

Specialty avg: 304

Specialty distribution in California

How Podiatrist compares to other specialties among California providers

California providers

Podiatrist share within California

1. Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Podiatrist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Podiatrist ABMS/AOA estimate

Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT KLEIMAN, D.P.M. appears in the CMS NPPES registry as a Podiatrist provider holding D.P.M. credentials at 120 W COLE BLVD STE B, CALEXICO, CA, 92231, with a listed phone of (760) 890-0190. NPI 1639132640 was issued on 04/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KLEIMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,454 prescription claims written by this provider, covering 418 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

120 W COLE BLVD STE B
CALEXICO, CA 92231

Provider Details

NPI 1639132640
Specialty Podiatrist
Credentials D.P.M.
Gender Male
NPI Issued 04/10/2006

Hospital and facility affiliations

Facilities where ROBERT KLEIMAN, D.P.M. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CLINICAS DEL VALLE A PROFESSIONAL CORP
CALEXICO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ROBERT KLEIMAN, D.P.M.. To verify ROBERT KLEIMAN, D.P.M.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ROBERT KLEIMAN, D.P.M. — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 2,454 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,454
Total Claims
$1.0M
Total Drug Cost
418
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,613
Total Day Supply
136,502
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$80K
Generic Drug Cost
$960K
Antibiotic Claims
46

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.97
Gender Split
60% female / 40% male
Age Distribution
<65: 66, 65-74: 211, 75-84: 106, 85+: 35

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROBERT KLEIMAN, D.P.M. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
372
Diclofenac Sodium
280
Betamethasone Dipropionate
195
Duloxetine Hcl
168
Lisinopril
163
Clotrimazole
145
Celecoxib
139
Ciclopirox
Ciclopirox Olamine
88
Tavaborole
77
Mupirocin
76

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Podiatrist Overview

How ROBERT KLEIMAN, D.P.M. fits within the Podiatrist landscape nationally.

10,498
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider

ROBERT KLEIMAN, D.P.M.'s 2,454 claims are above the specialty average of 304.

Nearby Podiatrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KLEIMAN.

Compare Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT KLEIMAN, D.P.M.'s specialty?
ROBERT KLEIMAN, D.P.M. specializes in Podiatrist and practices in CALEXICO, California. Credentials: D.P.M..
How much does ROBERT KLEIMAN, D.P.M. prescribe under Medicare Part D?
In 2023, ROBERT KLEIMAN, D.P.M. wrote 2,454 Medicare Part D claims totaling $1.0M in drug costs for 418 beneficiaries.
Where is ROBERT KLEIMAN, D.P.M. located?
ROBERT KLEIMAN, D.P.M. is located at 120 W COLE BLVD STE B, CALEXICO, CA, 92231. Phone: (760) 890-0190.
What is ROBERT KLEIMAN, D.P.M.'s NPI number?
ROBERT KLEIMAN, D.P.M.'s National Provider Identifier (NPI) is 1639132640, issued on 04/10/2006.
Does ROBERT KLEIMAN, D.P.M. prescribe more brand-name or generic drugs?
ROBERT KLEIMAN, D.P.M.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $80K in brand drug costs.
How many Podiatrist providers are there in the US?
There are 10,498 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does ROBERT KLEIMAN, D.P.M. prescribe most often?
Based on 2023 Medicare Part D data, ROBERT KLEIMAN, D.P.M.'s most frequently prescribed drugs include Ketoconazole, Diclofenac Sodium, Betamethasone Dipropionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT KLEIMAN, D.P.M. accept Medicare?
ROBERT KLEIMAN, D.P.M. appears in CMS Medicare data with 2,454 Part D claims and 418 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT KLEIMAN, D.P.M.'s credentials?
ROBERT KLEIMAN, D.P.M.'s NPI is 1639132640 with credentials D.P.M.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology